Biogen (BIIB) Tops Q1 EPS by 14c
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $220.83 --0%
Revenue Growth %: +4.3%
Financial Fact:
Total cost and expenses: 1.53B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +4.3%
Financial Fact:
Total cost and expenses: 1.53B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q1 EPS of $6.98, $0.14 better than the analyst estimate of $6.84. Revenue for the quarter came in at $3.5 billion versus the consensus estimate of $3.39 billion.
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
- UBS Downgrades Lai Yih Footwear Co Ltd (6890:TT) to Neutral
- AsiaStrategy adds Bitcoin-backed credit facility with Asian institution
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
